Navigation Links
Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021, Due to Increasing Prevalence of Fungal Toe Nail Infections

LONDON, Feb. 25, 2016 /PRNewswire/ -- Dermatophytic onychomycosis is a fungal nail infection caused by dermatophytes. Dermatophytic onychomycosis is also known as tinea unguium. It is called the dermatophytic invasion of the nail plate. It is the most common nail infection and constitutes more than half of all nail disease cases. This condition mostly affects toenails. The overall prevalence rate of dermatophytic onychomycosis is around 10% in the general population. The disease can lead to severe pain and can impede work and social activities.

This report covers the global dermatophytic onychomycosis therapeutics market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global dermatophytic onychomycosis therapeutics market. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to better equip clients with crystal clear decision-making insights.

The global dermatophytic onychomycosis therapeutics market is mainly driven by factors such as increasing the prevalence of dermatophytic onychomycosis, rising aging population, increasing consumer inclination towards maintaining aesthetic appearance of nails, and increasing per capita healthcare expenditure. Potential side effects of therapeutic products, availability of alternative treatments, and lack of awareness in emerging regions such as APEJ and MEA are expected to hinder the growth of the dermatophytic onychomycosis therapeutics market.

On the basis of products, dermatophytic onychomycosis therapeutics market is segmented into tablet and nail paint. Both the segments, tablet and nail paint are further sub-segmented into prescription and over-the-counter products. By distribution channel, dermatophytic onychomycosis therapeutics market is segmented into hospitals, clinics, independent pharmacies, mail order pharmacies, and drug stores.

By product, revenue from the tablet segment is projected to rise at the highest CAGR of 5.2% during the forecast period. The nail paint segment is expected to dominate the market, accounting for a maximum share of the overall market by 2021. The nail paint segment revenue is projected to rise at a CAGR of 8.3% during the forecast period (2015–2021).

By treatment, the topical segment is estimated to dominate the dermatophytic onychomycosis therapeutics market, accounting for a maximum share of the overall market by 2015 end. Revenue from the topical segment is projected to increase at a CAGR of 8.3% during the forecast period.

In terms of value, North America dominated the market with over 43% market share in 2014, followed by Europe. In Asia Pacific, this market is projected to expand at the highest CAGR of 5.1% during the forecast period.

Key players of the global dermatophytic onychomycosis therapeutics market are Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson Services, Inc., and Anacor Pharmaceuticals, Inc. Leading players operating in the market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.

The dermatophytic onychomycosis therapeutics market is segmented as follows:

By Product:
Prescription (Rx.)
Nail Paint
Prescription (Rx.)
By Treatment:
By Distribution Channels:
Independent Pharmacies
Mail Order Pharmacies
Drug Stores
By Region:
North America
Rest of Europe
Asia pacific
Australia & New Zealand
Rest of Asia Pacific
Latin America
Rest of Latin America
GCC Nations
South Africa
Rest of MEA

Key features included in this report:
Drivers and restraints of the dermatophytic onychomycosis therapeutics market
Latest product innovations and key developments in the market
Analysis of business strategies of the top players
Dermatophytic onychomycosis therapeutics market estimates and forecasts
Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +44 208 816 85 48

SOURCE ReportBuyer
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
(Date:7/19/2019)... SEATTLE (PRWEB) , ... July 19, 2019 , ... ... excited to announce the hiring of Chris Whaley as Senior Vice President of ... ways to make the patient experience better using cloud technology. , As a ...
(Date:7/19/2019)... HILLS, Calif. (PRWEB) , ... July 19, 2019 , ... ... Levin, L.M.F.T., is proud to announce the expansion of The Missing Peace with the ... for the Brain opens its doors July 19, 2019. , The Missing ...
(Date:7/19/2019)... ... 2019 , ... The San Francisco employment law attorneys ... lawsuit against Hospital Couriers Nevada, LLC, for allegedly failing to provide their workers ... periods. The class action also alleges that Hospital Couriers Nevada, LLC, failed to ...
Breaking Medicine Technology:
(Date:7/19/2019)... ... July 19, 2019 , ... Medtelligence , the ... as Senior Director of Education Strategy. Clem has extensive experience gained through key ... with physician experts on comprehensive educational programming, Megan brings a level of excellence ...
(Date:7/18/2019)... ... 2019 , ... LEAD Hospitality Group is preparing to participate in the 36th ... The event is scheduled to take place August 17, 2019 and will kick off ... the King & Queen Buildings. LEAD Hospitality Group will be attending with their running ...
(Date:7/18/2019)... LA JOLLA, Calif. (PRWEB) , ... July 18, 2019 , ... ... insight into their future children, announces a new publication titled, “ Accurate Fetal Sex ... Pregnancy & Child Birth. In the study, DNA blood samples were collected from 108 ...
(Date:7/17/2019)... Ky. (PRWEB) , ... July 17, 2019 , ... ... awarded to Eastern Kentucky University’s online Family Nurse Practitioner program. The honor is ... quality in distance education. , The Catalyst Awards honor institutions from around ...
(Date:7/17/2019)... ... July 17, 2019 , ... ICD10monitor, an online ... coding set, is launching an exclusive educational webcast subscription service featuring 40 original ... officials announced this week. , The ICD10monitor webcast portfolio already includes sought-after ...
Breaking Medicine News(10 mins):